UNSPSC 51372202: Dextropropoxyphene or propoxyphene

This classification denotes an opiate with the molecular formula C22H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S2F83W92TK, chemically known as 4-dimethylamino-3-methyl-1,2-diphenyl-2-propoxybutane but generally known as dextropropoxyphene, which bears US NIH Compound Identifier 10100. European Medicines Agency schedules Dextropropoxyphene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07053MIG. The term DEXTROPROPOXYPHENE is an International Non-Proprietary Name.

UNSPSC 51372202 Dextropropoxyphene or propoxyphene is a Commodity code that in current state and local procurement activity covers naloxone and drug deactivation systems procured to support public health and community safety initiatives. State and local health agencies and county governments are the primary issuing bodies under this code. The scope encompasses pharmaceutical products and associated safety equipment — specifically naloxone units and safe drug deactivation systems — purchased in bulk quantities with quarterly delivery requirements and often subject to federal compliance standards when procurement is funded through programs such as FEMA.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The procurement required electronic bid submission through the county's e-Procurement Portal, included unit-cost pricing for each line item, and mandated E-Verify compliance and drug-free workplace certification from vendors. The contract structure included a two-year initial term with an option for one-year renewal, quarterly delivery cycles, and vendor responsibility for all shipping costs. Recent opportunities under this code remain limited in the available data; the geographic and issuing-body spread cannot be fully characterized from a single recorded opportunity.